- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07629232
Measuring Corneal Parameters
June 1, 2026 updated by: Icare Finland Oy
Feasibility Study - Measuring Corneal Parameters
The aim of this clinical investigation is to assess the feasibility of the investigational device for measuring corneal parameters of the human eye.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maximilian Pfau, Prof.
- Phone Number: +4915164672802
- Email: Maximilian.Pfau@ukbonn.de
Study Locations
-
-
North Rhine-Westphalia
-
Bonn, North Rhine-Westphalia, Germany, 53127
- Universitäts-Augenklinik Bonn
-
Contact:
- Maximilian Pfau, Prof.
- Phone Number: +4915164672802
- Email: Maximilian.Pfau@ukbonn.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
1. Age ≥ 18 years
Exclusion Criteria:
- Subjects with only one functional eye
- Subjects having poor or eccentric fixation in the study eye(s)
- Central corneal scarring (that might affect the measurement result)
- Microphthalmos
- Buphthalmos
- Contact lens use (12 hours prior to measurements)
- Severe dry eyes
- Lid squeezers - blepharospasm
- Nystagmus
- Any other corneal or conjunctival pathology or condition that prevents CCT measurements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Measurement with the investigational device
|
Measurement of corneal parameters
|
|
Experimental: Measurement with Zeiss IOL Master 700
|
Measurement of corneal parameters
|
|
Experimental: Measurement with Heidelberg Anterion
|
Measurement of corneal parameters
|
|
Experimental: Measurement with Nidek NT-530P
|
Measurement of corneal parameters
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The primary objective of this study is to collect a comprehensive dataset of central corneal thickness (CCT) values to assess the performance of investigational device.
Time Frame: Through study completion, an average of 2 months
|
Through study completion, an average of 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 27, 2026
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Study Registration Dates
First Submitted
May 22, 2026
First Submitted That Met QC Criteria
June 1, 2026
First Posted (Actual)
June 5, 2026
Study Record Updates
Last Update Posted (Actual)
June 5, 2026
Last Update Submitted That Met QC Criteria
June 1, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- TA05-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Parameters
-
Aristotle University Of ThessalonikiPapageorgiou General HospitalRecruitingCorneal Densitometry | Pseudoexfoliation Syndrome | Biomechanical ParametersGreece
-
University Hospital, Clermont-FerrandCompleted
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Not yet recruitingPhysiological ParametersFrance
-
University of HohenheimActive, not recruitingPharmacokinetic ParametersGermany
-
Mutah UniversityCompletedPharmacokinetic ParametersJordan
-
University Hospital, Clermont-FerrandService Biologie de la reproduction-CECOSUnknownSpermatic Parameters | Embryonic KineticsFrance
-
Henrique SousaUniversity Institute of Maia; Portugal Football School, Federação Portuguesa...RecruitingPhysical Performance ParametersPortugal
-
University Institute of MaiaNot yet recruitingPhysical Performance ParametersPortugal
-
University Institute of MaiaNot yet recruitingPhysical Performance ParametersPortugal
-
University Institute of MaiaRecruitingPhysical Perfrormance ParametersPortugal
Clinical Trials on Investigational device
-
Coloplast A/SCompleted
-
Perrigo CSCIRecruiting
-
Össur Iceland ehfCompletedAmputation | Prosthesis User
-
NanoVationCompletedChronic Obstructive Pulmonary Disease (COPD)Israel
-
CLASSYS Inc.Not yet recruitingAcne Scars | Acne Scarring | Acne Scar | Acne Scars - AtrophicChina
-
Cutera Inc.CompletedPigmented Skin Lesion of Suspected Benign NatureUnited States
-
Jacobs instituteUniversity at BuffaloCompletedIschemic StrokeUnited States
-
Noctrix Health, Inc.Active, not recruitingRestless Legs SyndromeUnited States
-
Perimeter Medical ImagingCancer Prevention Research Institute of TexasCompletedBreast Cancer FemaleUnited States
-
Kansas City Heart Rhythm Research FoundationNot yet recruitingAtrial Fibrillation